Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $3.85 Million - $4.35 Million
20,106 Added 20.01%
120,606 $25.6 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $5.66 Million - $6.22 Million
30,150 Added 42.86%
100,500 $19.3 Million
Q1 2023

May 15, 2023

SELL
$127.59 - $203.08 $22.9 Million - $36.5 Million
-179,564 Reduced 71.85%
70,350 $14.2 Million
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $29.3 Million - $34.8 Million
249,914 New
249,914 $32.1 Million
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $128 Million - $211 Million
-1,174,073 Reduced 83.4%
233,620 $41.3 Million
Q1 2022

May 16, 2022

BUY
$119.61 - $157.85 $88.5 Million - $117 Million
739,689 Added 110.73%
1,407,693 $203 Million
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $12.9 Million - $17.2 Million
90,300 Added 15.63%
668,004 $103 Million
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $6,980 - $8,321
49 Added 0.01%
577,704 $98.1 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $71.2 Million - $84.9 Million
526,768 Added 1035.17%
577,655 $91.2 Million
Q1 2021

May 17, 2021

BUY
$137.51 - $190.8 $149,885 - $207,972
1,090 Added 2.19%
50,887 $7.07 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $8.2 Million - $10.6 Million
49,797 New
49,797 $8.72 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.